ANVS insider transaction filings
Annovis Bio, Inc. — 22 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-05-21. Screen ANVS transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for ANVS between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.
Recent Form 4 filings — Annovis Bio, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-21 | 4 | Hoffman Michael B — Director | Purchase (P): 2,562 @ $1.75 · Purchase (P): 18,849 @ $1.80 · Purchase (P): 54,933 @ $1.90 | EDGAR |
| 2026-04-03 | 4 | Hoffman Michael B — Director | Purchase (P): 713,800 @ $2.10 | EDGAR |
| 2025-12-08 | 4 | Hoffman Michael B — Director | Purchase (P): 30,000 @ $4.34 · Purchase (P): 15,000 @ $4.24 | EDGAR |
| 2025-11-25 | 4 | Hoffman Michael B — Director | Purchase (P): 1,489 @ $4.13 · Purchase (P): 9,200 @ $3.85 · Purchase (P): 415 @ $4.14 · Purchase (P): 28,096 @ $4.15 | EDGAR |
| 2025-11-25 | 4/A | Hoffman Michael B — Director | Purchase (P): 1,489 @ $4.13 · Purchase (P): 9,200 @ $3.85 · Purchase (P): 415 @ $4.14 · Purchase (P): 28,096 @ $4.15 | EDGAR |
| 2025-11-21 | 4 | Hoffman Michael B — Director | Purchase (P): 10,000 @ $3.49 · Purchase (P): 10,000 @ $3.50 | EDGAR |
| 2025-11-18 | 4 | Hoffman Michael B — Director | Purchase (P): 15,000 @ $2.11 | EDGAR |
| 2025-11-12 | 4 | Bruck Claudine — Director | Option exercise (M): 7,142 @ $0.14 · Option exercise (M): 7,142 (derivative) @ $0 | EDGAR |
| 2025-11-12 | 4 | Maccecchini Maria-Luisa — President & CEO, Director | Purchase (P): 97,561 @ $2.05 | EDGAR |
| 2025-11-12 | 4 | Hoffman Michael B — Director | Purchase (P): 975,610 @ $2.05 | EDGAR |
| 2025-09-03 | 4 | Hoffman Michael B — Director | Grant/award (A): 5,000 @ $2.28 · Grant/award (A): 5,000 @ $2.29 · Grant/award (A): 5,000 @ $2.30 | EDGAR |
| 2025-08-20 | 4 | Hoffman Michael B — Director | Grant/award (A): 6,717 @ $2.60 · Grant/award (A): 5,283 @ $2.59 · Grant/award (A): 5,545 @ $2.58 · Grant/award (A): 1,100 @ $2.57 | EDGAR |
| 2025-06-18 | 4 | Walsh Andrew — Vice President, Finance | Grant/award (A): 500 @ $2.90 | EDGAR |
| 2025-06-16 | 4 | Hoffman Michael B — Director | Grant/award (A): 25,000 @ $2.80 · Grant/award (A): 1 @ $2.83 | EDGAR |
| 2025-06-11 | 4 | McCarthy Reid — Director | Grant/award (A): 2,000 @ $2.95 | EDGAR |
| 2025-06-05 | 4 | Maccecchini Maria-Luisa — President & CEO, Director | Grant/award (A): 46,000 @ $3.37 | EDGAR |
| 2025-06-02 | 4 | Hoffman Michael B — Director | Grant/award (A): 5,000 @ $2.43 | EDGAR |
| 2024-07-03 | 4 | White Mark K. — Director | Grant/award (A): 26,200 (derivative) @ $0 · Grant/award (A): 2,146 (derivative) @ $0 · Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2024-07-03 | 4 | McCarthy Reid — Director | Grant/award (A): 29,600 (derivative) @ $0 | EDGAR |
| 2024-07-03 | 4 | Bruck Claudine — Director | Grant/award (A): 26,200 (derivative) @ $0 | EDGAR |
| 2024-07-03 | 4 | Maccecchini Maria-Luisa — President and CEO, Director, 10% owner | Gift (G): 10,000 @ $0 · Gift (G): 10,000 @ $0 · Gift (G): 10,000 @ $0 · Grant/award (A): 252,000 (derivative) @ $0 · Grant/award (A): 108,800 (derivative) @ $0 | EDGAR |
| 2024-07-03 | 4 | Hoffman Michael B — Director, 10% owner | Grant/award (A): 29,600 (derivative) @ $0 | EDGAR |
Recent 8-K events — Annovis Bio, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-10 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-17 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-20 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-15 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-10 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-25 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-16 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-12 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-28 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ANVS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →